In various studies for anti-obesity treatment, increased adiponectin expression has been accepted as a major target, which has demonstrated therapeutic benefits in animal models [59, 60]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.